Xingqi Pharmaceutical has decided to terminate its private placement of A-shares, citing market conditions and its development plans. The company has withdrawn its application documents with the Shenzhen Stock Exchange, stating this decision will not significantly impact its operations. Separately, shareholders of Zhongxin Saike plan to reduce their holdings by up to 1.84% of the company's total share capital. AI
Summary written by gemini-2.5-flash-lite from 1 sources. How we write summaries →
RANK_REASON The cluster contains multiple unrelated news items, including a company terminating a funding round and shareholder divestments, presented in a digest format.